Company
Transenterix
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
9
510(k), De Novo and PMA
Device trials
0
As lead sponsor, any status
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
Recall records
4
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.
Total raised (reported)
$58.4M
5 Form D offerings, 2009 to 2017
Equity
$55.4M
Stock sold for cash
Debt and convertible notes
$2.0M
$2.0M of it convertible
Last known valuation
Unknown
Form D filings do not report valuation
Latest round: options or warrants, $950K raised of $950K sought, first sale Sep 12, 2017, 1 investor. $950K was in other or unstated securities.
Funding rounds (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| Sep 12, 2017 | Options or warrants | $950K | $950K | 1 | Rule 506(b) | Form D ↗Sep 15, 2017 |
| Sep 14, 2016 | Equity | $116K | $214K | 1 | Rule 506(b) | Form D ↗Sep 23, 2016 |
| Aug 5, 2013 | Convertible note | $2.0M | $2.5M | 9 | Rule 506 | Form D ↗Aug 9, 2013 |
2 more funding rounds with a free account
Company details
From the company's latest Form D.
- Legal name
- TRANSENTERIX INC.; TRANSENTERIX INC
- Headquarters
- Morrisville, North Carolina
- Incorporated
- Delaware over five years before filing
- Entity type
- Corporation
- Revenue range
- Decline to Disclose
- Industry filed under
- Other Health Care
- SEC filer
- CIK 876378 ↗, CIK 1423503 ↗
Executives, directors and promoters
As listed on the latest Form D.
11 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Transenterix.
Latest FDA decisions
The 8 newest of 9 since 2015.
- Senhance Surgical System510(k)
K202166 · Decided Mar 2, 2021 · 211 days after receipt
Device type: System, Surgical, Computer Controlled Instrument (NAY) · GI, Urology & Nephrology
- Senhance Surgical System510(k)
K200049 · Decided Mar 9, 2020 · 60 days after receipt
Device type: System, Surgical, Computer Controlled Instrument (NAY) · GI, Urology & Nephrology
- Senhance Surgical System510(k)
K192877 · Decided Nov 22, 2019 · 45 days after receipt
Device type: System, Surgical, Computer Controlled Instrument (NAY) · GI, Urology & Nephrology
6 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
No device trials list this company as lead sponsor.
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
No reports to chart for this view.
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
No device types to rank.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
No brand names to rank.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2137-2012 · Started Jul 2, 2012 · Posted by FDA Aug 3, 2012
Reason given: Some clip applier units may be inadequate to achieve clip closure.
Cause as FDA categorized it: Process control · Device type: Laparoscope, General & Plastic Surgery (GCJ)
Z-1909-2011 · Started Feb 25, 2011 · Posted by FDA Apr 8, 2011
Reason given: Plastic shards may break off and fall into the abdominal space which may require retrieval during surgery.
Cause as FDA categorized it: Other · Device type: Laparoscope, General & Plastic Surgery (GCJ)
Z-1910-2011 · Started Feb 25, 2011 · Posted by FDA Apr 8, 2011
Reason given: Plastic shards may break off and fall into the abdominal space which may require retrieval during surgery.
Cause as FDA categorized it: Other · Device type: Laparoscope, General & Plastic Surgery (GCJ)
1 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.